Paola Grandi
Functional Genomics R&D
Heidelberg, BW 69117, Germany
Heidelberg, BW 69117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
BET Isoform Selectivity through Diverse Linkers for Bivalent Inhibitors: GSK785, a BRD2/4-Selective Bivalent BET Inhibitor.
Journal: Journal of medicinal chemistry
Published: December 30, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.
Journal: Journal for immunotherapy of cancer
Published: February 05, 2025
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation.
Journal: Cancer research communications
Published: January 17, 2024
Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition.
Journal: Molecular systems biology
Published: January 17, 2024
Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression.
Journal: Nature genetics
Published: July 27, 2023
mRNA export factors store nascent transcripts within nuclear speckles as an adaptive response to transient global inhibition of transcription.
Journal: Molecular cell
Published: June 06, 2023
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.
Journal: Nature cancer
Published: November 18, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 14, 2021
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 13, 2021
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit.
Journal: Journal of medicinal chemistry
Published: July 12, 2021
Identification of a Series of N-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) Proteins.
Journal: Journal of medicinal chemistry
Published: July 07, 2021
Last Updated: 09/26/2026